Hong Kong-headquartered venture capital (VC) firm E15VC has closed its third fund at $60.75 million, which will focus on global deep-tech investments, according to a company announcement on Tuesday.
The fund, which has a 10-year life, is anchored by Hong Kong’s alternative investments firm, Sun Hung Kai (SHK) & Co, which invests in public markets, alternatives, and real assets, with HK$49 billion ($6.2 billion) in assets under management. The deal was arranged by Sun Hung Kai Capital Partners Limited, the fund management arm of SHK & Co.
Founded in 2017 by Philip Liang, an MIT graduate, E15VC is a deep-tech focused, stage-agnostic VC firm.
Its portfolio companies include mental health SaaS platform Frankie, software development company Celebrity Agent, medical equipment manufacturer Caeli Vascular, and edtech startup SAM Labs. It was also an investor in Auris Health, a surgical robotics company which was acquired by Johnson and Johnson in 2019.
Philip Liang, Managing Partner of E15VC, said: “We look forward to identifying, investing, and supporting mission-driven entrepreneurs, and helping them reach their next stages of growth. This third fund represents a significant milestone for the firm.”
In January last year, E15VC closed its second fund at $32 million, with Sun Hung Kai committing $15 million.
Lindsay Wright, CEO of SHK Capital Partners, said: “We continue to have confidence in their [EC15VC] ability to access leading entrepreneurs around the world and execute on compelling investments.”
SHK & Co, a leading financial services and alternative investment firm, is expanding its external partnerships, including seeding, distribution, and providing acceleration capital as it grows its funds management platform — SHK Capital Partners.